Caroline Christine Pincela da Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Caroline Christine Pincela da Costa has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Rodrigo da Silva Santos
Universidade Federal de Goiás, Brasil; Universidade Federal de Goiás, Brasil
6 shared publications - Angela Adamski da Silva Reis
Universidade Federal de Goiás, Brasil; Universidade Federal de Goiás, Brasil
5 shared publications - Kamilla de Faria Santos
Universidade Federal de Goiás, Brasil
3 shared publications - Leandro Do Prado Assunção
Universidade Federal de Goiás
2 shared publications - Amanda Ferreira Paes Landim Ramos
Universidade Federal de Goiás, Brasil
1 shared publication - Dhiogo da Cruz Pereira Bento
Núcleo de Pesquisas em Neurogenética (NeuroGene), Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiania 74690-900, Goiás, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69, e26250464
Genetic Polymorphisms as Biomarkers of Neuroinflammation Pathway in Neurodegenerative Sclerosis: A Systematic Review and Meta-Analysis
Degenerative sclerosis, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) are progressive diseases affecting neuronal cells, impairing muscle tone and mobility. Both pathologies have a multifactorial etiology. However, inflammation plays a significant role in neuron injury, and the genetic background can influence its susceptibility and progression. In this context, we perform a systematic review and meta-analysis aiming to identify the genetic polymorphisms that directly activate inflammatory pathways to neurodegeneration. Through research in EMBASE, SCOPUS, Web of Science, Pubmed/NCBI, and virtual health library (BVS) databases, on observational studies that addressed polymorphisms and direct neuroinflammation in ALS and/or MS presenting a statistically significant association. Studies on non-humans, non-observational reports, studies reporting indirect activation of inflammatory pathways, protective genetic association, or susceptibility only to the diseases’ progression were excluded. The methodological quality of the individual studies was assessed by Joanna Briggs Critical Appraisal Tools. Forty-two studies were included by a qualitative synthesis in this systematic review, and five polymorphisms were evaluated in the meta-analysis. For MS, the gene superfamily of interleukins was frequently reported, while VEGF-A was the major cytokine associated with ALS. In the meta-analysis, the SNPs rs2069762 in IL2, rs3212227 in IL12Β, rs1946518 in IL18, and rs3918242 in MMP9 were associated with MS susceptibility. No association was found for rs1800750 in the TNF-α gene. Despite limitations, such as the small sample size, this review highlights key genes and polymorphisms in neuroinflammatory pathways, offering insights for developing a genetic panel targeting ALS and MS susceptibility.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69, e26250464
Open AccessGenetic Polymorphisms as Biomarkers of Neuroinflammation Pathway in Neurodegenerative Sclerosis: A Systematic Review and Meta-Analysis
Degenerative sclerosis, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) are progressive diseases affecting neuronal cells, impairing muscle tone and mobility. Both pathologies have a multifactorial etiology. However, inflammation plays a significant role in neuron injury, and the genetic background can influence its susceptibility and progression. In this context, we perform a systematic review and meta-analysis aiming to identify the genetic polymorphisms that directly activate inflammatory pathways to neurodegeneration. Through research in EMBASE, SCOPUS, Web of Science, Pubmed/NCBI, and virtual health library (BVS) databases, on observational studies that addressed polymorphisms and direct neuroinflammation in ALS and/or MS presenting a statistically significant association. Studies on non-humans, non-observational reports, studies reporting indirect activation of inflammatory pathways, protective genetic association, or susceptibility only to the diseases’ progression were excluded. The methodological quality of the individual studies was assessed by Joanna Briggs Critical Appraisal Tools. Forty-two studies were included by a qualitative synthesis in this systematic review, and five polymorphisms were evaluated in the meta-analysis. For MS, the gene superfamily of interleukins was frequently reported, while VEGF-A was the major cytokine associated with ALS. In the meta-analysis, the SNPs rs2069762 in IL2, rs3212227 in IL12Β, rs1946518 in IL18, and rs3918242 in MMP9 were associated with MS susceptibility. No association was found for rs1800750 in the TNF-α gene. Despite limitations, such as the small sample size, this review highlights key genes and polymorphisms in neuroinflammatory pathways, offering insights for developing a genetic panel targeting ALS and MS susceptibility.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Genomic prediction of diabetic retinopathy via VEGF-A variants: insights from meta-analysis, machine learning and molecular docking approaches
Diabetic retinopathy (DR) is a complex ocular microvascular neurodegenerative condition resulting from chronic hyperglycemia and hypoxia. Genetic variants, particularly in the vascular endothelial growth factor A (VEGF-A) gene, play a key role in promoting pathological angiogenesis. This study conducted a systematic review and meta-analysis to identify key VEGF-A variants associated with DR development. Observational studies were retrieved from PubMed/Medline, Web of Science, Virtual Health Library, Embase, and Scopus, without time restrictions. Moreover, machine learning (ML) models were applied to enhance genetic risk prediction for DR. Additionally, molecular docking was performed to assess the impact of the −460T>C single-nucleotide variant (SNV) on the interaction between the VEGF-A promoter and the HIF1 transcription factor. Of the 20 studies included in the systematic review, 14 were eligible for meta-analysis. A significant association was found between the C allele of the rs833061 (−460T>C) variant and DR risk (OR = 1.49; 95% CI = 1.17–1.90; p = 0.0014), as well as in the dominant genotypic model (TT vs. TC + CC; OR = 1.76; 95% CI = 1.13–2.74; p = 0.0130). Although the −2549 I/D variant was not significant in the meta-analysis, ML models indicated its predictive value. Molecular docking revealed enhanced binding affinity of the −460C allele to HIF1, suggesting functional relevance. In conclusion, these findings support the potential of VEGF-A variants, particularly rs833061, as biomarkers for DR susceptibility and highlight the utility of integrating ML and molecular docking for predictive medicine.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 86
Open AccessGenomic prediction of diabetic retinopathy via VEGF-A variants: insights from meta-analysis, machine learning and molecular docking approaches
Diabetic retinopathy (DR) is a complex ocular microvascular neurodegenerative condition resulting from chronic hyperglycemia and hypoxia. Genetic variants, particularly in the vascular endothelial growth factor A (VEGF-A) gene, play a key role in promoting pathological angiogenesis. This study conducted a systematic review and meta-analysis to identify key VEGF-A variants associated with DR development. Observational studies were retrieved from PubMed/Medline, Web of Science, Virtual Health Library, Embase, and Scopus, without time restrictions. Moreover, machine learning (ML) models were applied to enhance genetic risk prediction for DR. Additionally, molecular docking was performed to assess the impact of the −460T>C single-nucleotide variant (SNV) on the interaction between the VEGF-A promoter and the HIF1 transcription factor. Of the 20 studies included in the systematic review, 14 were eligible for meta-analysis. A significant association was found between the C allele of the rs833061 (−460T>C) variant and DR risk (OR = 1.49; 95% CI = 1.17–1.90; p = 0.0014), as well as in the dominant genotypic model (TT vs. TC + CC; OR = 1.76; 95% CI = 1.13–2.74; p = 0.0130). Although the −2549 I/D variant was not significant in the meta-analysis, ML models indicated its predictive value. Molecular docking revealed enhanced binding affinity of the −460C allele to HIF1, suggesting functional relevance. In conclusion, these findings support the potential of VEGF-A variants, particularly rs833061, as biomarkers for DR susceptibility and highlight the utility of integrating ML and molecular docking for predictive medicine.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e290851
Association between genetic polymorphisms and host susceptibility to Helicobacter pylori infection: a systematic review and meta-analysis
Host genetic polymorphisms are predictive markers of susceptibility to infections. The gram-negative bacterium Helicobacter pylori can cause inflammation and molecular changes with various clinical outcomes. This study aimed to characterize host molecular biomarkers associated with susceptibility to H. pylori infection through a systematic review using PRISMA guidelines. The research was conducted across five databases, selecting observational studies without time or language restrictions and excluding animal studies. The protocol was registered in PROSPERO (CRD42023409085). Out of 4.683 articles, 35 were included, identifying 43 polymorphisms in 30 genes. 06 polymorphisms were analyzed in the meta-analysis: IL1B-C31T (rs1143627), IL1B-C511T (rs16944), TLR1 C>T (rs4833095), TLR4 A>G (rs4986790), TLR10 A>T (rs10004195), and TNF308 G>A (rs1800629). IL1B-C511T and TLR4 A>G increased susceptibility, while TLR1 C>T and TLR10 A>T offered protection. Host genetic determinants are strongly related to infection susceptibility. This study identified genomic variants and characterized the host genetic risk profile, contributing to targeted approaches for the target population and personalized medicine in the prevention, diagnosis, and treatment of H. pylori infection.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e290851
Open AccessAssociation between genetic polymorphisms and host susceptibility to Helicobacter pylori infection: a systematic review and meta-analysis
Host genetic polymorphisms are predictive markers of susceptibility to infections. The gram-negative bacterium Helicobacter pylori can cause inflammation and molecular changes with various clinical outcomes. This study aimed to characterize host molecular biomarkers associated with susceptibility to H. pylori infection through a systematic review using PRISMA guidelines. The research was conducted across five databases, selecting observational studies without time or language restrictions and excluding animal studies. The protocol was registered in PROSPERO (CRD42023409085). Out of 4.683 articles, 35 were included, identifying 43 polymorphisms in 30 genes. 06 polymorphisms were analyzed in the meta-analysis: IL1B-C31T (rs1143627), IL1B-C511T (rs16944), TLR1 C>T (rs4833095), TLR4 A>G (rs4986790), TLR10 A>T (rs10004195), and TNF308 G>A (rs1800629). IL1B-C511T and TLR4 A>G increased susceptibility, while TLR1 C>T and TLR10 A>T offered protection. Host genetic determinants are strongly related to infection susceptibility. This study identified genomic variants and characterized the host genetic risk profile, contributing to targeted approaches for the target population and personalized medicine in the prevention, diagnosis, and treatment of H. pylori infection.
- 17 June 2023
- Published by Rfb Editora
IMMUNOGENETICS OF NEURODEGENERATIVE SCLEROSES: AMYOTROPHIC LATERAL SCLEROSIS AND MULTIPLE SCLEROSIS
IMMUNOGENETICS OF NEURODEGENERATIVE SCLEROSES
- 17 June 2023
- Published by Rfb Editora
IMMUNOGENETICS OF NEURODEGENERATIVE SCLEROSES: AMYOTROPHIC LATERAL SCLEROSIS AND MULTIPLE SCLEROSIS
IMMUNOGENETICS OF NEURODEGENERATIVE SCLEROSES
- Open Access
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use.
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Open AccessNeutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) as neuroinflammatory biomarkers in Amyotrophic Lateral Sclerosis (ALS) progression
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing multisystemic and multifactorial neurodegenerative disease that affects upper and lower motor neurons. Neuroinflammation is an important factor in neurodegeneration, the increase of immune cells in the neural tissue and degranulation of these cells causes neuronal damage and death, thus playing an important role in ALS pathophysiology. Studies have sought to use the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) as biomarkers of the inflammatory response indicative of diagnosis, stratification, progression and response to treatment of several diseases, including neurodegenerative. Thus, the aim of this study was to evaluate NLR and PLR as possible biomarkers in the neurodegenerative process. This retrospective cross-sectional study was carried out with 43 ALS patients selected at the Dr. Henrique Santillo Rehabilitation and Readaptation Center (CRER), Goiânia, Goiás – Brazil. Neutrophil, platelet, and lymphocyte counts were collected from the patient's most recent hemogram. Statistical analysis was performed using SPSS software, version 26. The correlation between NLR and PLR according to clinical condition showed a significant difference in these parameters during the initial phase of ALS development (p=0.01), revealing a marked inflammatory, with subsequent decline as the disease progresses (p=0.06). Furthermore, the results indicated a moderate positive linear relationship between the two variables (r=0.57; p<0.001), showing a joint increase in these parameters. Therefore, NLR and PLR are important indicators of inflammation and can be useful due to their simplicity, high reproducibility and low-cost for routine use.
- Open Access
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Sintomatologia de depressão autorreferida por pacientes oncológicos em tempos de pandemia da COVID-19
Estudo transversal realizado com pacientes oncológicos com objetivo de estimar a prevalência de sintomas da depressão em tempos de pandemia da COVID-19. A coleta de dados foi realizada através da HADS (Hospital Anxiety and Depression Scale) 108 pacientes portadores de doenças oncológicas participaram deste estudo. Realizou-se uma análise descritiva e estatística para verificar a associação entre as variáveis. Utilizamos o teste qui-quadrado entre as variáveis com nível de significância de 0,05. Apenas as variáveis depressão e ansiedade, depressão e trabalho apresentaram estatística significativa com valor de p menor que 0,05. A partir desses resultados foi feita uma regressão logística e o cálculo do odds ratio entre as variáveis ‘depressão’, ‘trabalho’ e ‘ansiedade’, no qual observa-se que pessoas que já trabalharam e não trabalham mais, tem uma maior chance (3,36 vezes) de apresentar um quadro de depressão. Além de tudo, pessoas com ansiedade também apresentam maiores chances (14,86 vezes) de depressão.
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Open AccessSintomatologia de depressão autorreferida por pacientes oncológicos em tempos de pandemia da COVID-19
Estudo transversal realizado com pacientes oncológicos com objetivo de estimar a prevalência de sintomas da depressão em tempos de pandemia da COVID-19. A coleta de dados foi realizada através da HADS (Hospital Anxiety and Depression Scale) 108 pacientes portadores de doenças oncológicas participaram deste estudo. Realizou-se uma análise descritiva e estatística para verificar a associação entre as variáveis. Utilizamos o teste qui-quadrado entre as variáveis com nível de significância de 0,05. Apenas as variáveis depressão e ansiedade, depressão e trabalho apresentaram estatística significativa com valor de p menor que 0,05. A partir desses resultados foi feita uma regressão logística e o cálculo do odds ratio entre as variáveis ‘depressão’, ‘trabalho’ e ‘ansiedade’, no qual observa-se que pessoas que já trabalharam e não trabalham mais, tem uma maior chance (3,36 vezes) de apresentar um quadro de depressão. Além de tudo, pessoas com ansiedade também apresentam maiores chances (14,86 vezes) de depressão.
- Open Access
- 10 June 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (7)
Neurotropismo de SARS-CoV-2: Possíveis impactos da COVID-19 em portadores de Esclerose Lateral Amiotrófica
A esclerose lateral amiotrófica é uma doença neuromuscular degenerativa que acomete os neurônios motores superiores e inferiores. O estado de debilitação motora e funcional decorrente da progressão da doença os expõe a um risco possivelmente fatal no caso de infeção pelo SARS-CoV-2, especialmente devido ao severo acometimento pulmonar, característico do avanço da patologia degenerativa em questão. Nesta revisão, elencamos os principais mecanismos associativos entre a doença e a COVID-19, destacando, principalmente, os aspectos virais neuroinvasivos. O estudo trata-se de uma pesquisa qualitativa descritiva, realizada mediante revisão narrativa da literatura. A literatura acerca do novo coronavírus tem demonstrado a capacidade viral de neuroinvasão e neurotrópica do SARS-CoV-2. Atualmente, as evidências comprovam que a infecção não é restrita ao trato respiratório, o qual é o sítio primário da infecção. Com base nos achados, propõe-se a existência de três cenários viáveis no impacto do SARS-CoV-2 e a neuroinvasão: (1) indução, de forma direta, às alterações neurológicas; (2) agravamento de condições neurológicas previamente instaladas; e (3) aumento na susceptibilidade ou da deterioração de danos provocados por outras injúrias, nesse caso, considerando os portadores de ELA. Conclui-se que existe a possibilidade de um período latente do SARS-CoV-2 no SNC. Dessa forma, é crucial a observação de sintomas neurológicos posteriores no individuo, decorrentes da reativação viral, resultando em progressão continua dos processos neuroinflamatórios associados à ELA. As capacidades neuroinvasivas e neurotrópicas do vírus também devem ser observadas em longo prazo para elucidar se as doenças neurodegenerativas, como a ELA conferem vulnerabilidade direta a COVID-19.
- 10 June 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (7)
Open AccessNeurotropismo de SARS-CoV-2: Possíveis impactos da COVID-19 em portadores de Esclerose Lateral Amiotrófica
A esclerose lateral amiotrófica é uma doença neuromuscular degenerativa que acomete os neurônios motores superiores e inferiores. O estado de debilitação motora e funcional decorrente da progressão da doença os expõe a um risco possivelmente fatal no caso de infeção pelo SARS-CoV-2, especialmente devido ao severo acometimento pulmonar, característico do avanço da patologia degenerativa em questão. Nesta revisão, elencamos os principais mecanismos associativos entre a doença e a COVID-19, destacando, principalmente, os aspectos virais neuroinvasivos. O estudo trata-se de uma pesquisa qualitativa descritiva, realizada mediante revisão narrativa da literatura. A literatura acerca do novo coronavírus tem demonstrado a capacidade viral de neuroinvasão e neurotrópica do SARS-CoV-2. Atualmente, as evidências comprovam que a infecção não é restrita ao trato respiratório, o qual é o sítio primário da infecção. Com base nos achados, propõe-se a existência de três cenários viáveis no impacto do SARS-CoV-2 e a neuroinvasão: (1) indução, de forma direta, às alterações neurológicas; (2) agravamento de condições neurológicas previamente instaladas; e (3) aumento na susceptibilidade ou da deterioração de danos provocados por outras injúrias, nesse caso, considerando os portadores de ELA. Conclui-se que existe a possibilidade de um período latente do SARS-CoV-2 no SNC. Dessa forma, é crucial a observação de sintomas neurológicos posteriores no individuo, decorrentes da reativação viral, resultando em progressão continua dos processos neuroinflamatórios associados à ELA. As capacidades neuroinvasivas e neurotrópicas do vírus também devem ser observadas em longo prazo para elucidar se as doenças neurodegenerativas, como a ELA conferem vulnerabilidade direta a COVID-19.